Document Details
Form
Filing Date
February 16, 2021
Document Date
February 12, 2021
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Protalix BioTherapeutics
Issuer
PROTALIX BIOTHERAPEUTICS, INC.
Filer
Dexcel Pharma Technologies Ltd.